Literature DB >> 8266980

The role of Helicobacter pylori in acid-peptic disease.

A J DeCross1, B J Marshall.   

Abstract

Acid peptic disease is common, and its management is costly. Less than a decade ago, the traditional theories regarding the etiology and pathogenesis of acid peptic disease were upset by the discovery of Helicobacter pylori infection in association with chronic active gastritis. A substantial body of investigation after that discovery has established this infection as the major cause of human chronic active gastritis and has defined a critical role for H. pylori in the etiology, pathophysiology, and treatment of duodenal ulcer disease. Furthermore, evidence is accumulating to link H. pylori to gastric ulcers, non-ulcer dyspepsia, and even gastric carcinoma. Research has clarified some unique features of the organism that have been put to advantage in the development of diagnostic tests, and it has also clarified some features of the infection that make it difficult to treat. Although treatment is decidedly beneficial for certain patient subsets, simpler and more effective therapy is needed.

Entities:  

Mesh:

Year:  1993        PMID: 8266980     DOI: 10.1097/00000441-199312000-00006

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

Review 1.  Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses.

Authors:  H M Davey; D B Kell
Journal:  Microbiol Rev       Date:  1996-12

2.  Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.

Authors:  M H Derakhshan; E El-Omar; K Oien; D Gillen; V Fyfe; J E Crabtree; K E L McColl
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

Review 3.  Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders.

Authors:  A Markham; D McTavish
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

4.  Recognition of glycoconjugates by Helicobacter pylori: an apparently high-affinity binding of human polyglycosylceramides, a second sialic acid-based specificity.

Authors:  H Miller-Podraza; M A Milh; J Bergström; K A Karlsson
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

5.  Activities of beta-lactams and macrolides against Helicobacter pylori.

Authors:  I J Hassan; R M Stark; J Greenman; M R Millar
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  Recognition of glycoconjugates by Helicobacter pylori. Comparison of two sialic acid-dependent specificities based on haemagglutination and binding to human erythrocyte glycoconjugates.

Authors:  H Miller-Podraza; J Bergström; M A Milh; K A Karlsson
Journal:  Glycoconj J       Date:  1997-06       Impact factor: 2.916

Review 7.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

8.  Current status of peptic ulcer disease in Port Harcourt metropolis, Nigeria.

Authors:  Emeka Ray-Offor; Kalanne Ada Opusunju
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.